Nutrition Research
Volume 25, Issue 3 , Pages 305-317 , March 2005

Absorption, distribution, and secretion of epicatechin and quercetin in the rat

Received 30 November 2003 ,Revised 22 December 2003 ,Accepted 14 October 2004.

References 

  1. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavanoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 1995;155:381–386
  2. King A, Young G. Characteristics and occurrence of phenolic phytochemicals. J. Am. Diet. Assoc. 1999;99:213–218
  3. Peterson J, Dwyer J. Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. J. Am. Diet. Assoc. 1998;98:677–685
  4. Hollman PCH, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 1999;37:937–942
  5. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 1993;18:1–29
  6. Chung SY. Tea and health. Nutrition. 1999;15:946–949
  7. Dufresne CJ, Farnworth ER. A review of latest research findings on the health promotion properties of tea. J. Nutr. Biochem. 2001;12:404–421
  8. Scalbert A, Morand C, Manach C, Remesy C. Absorption and metabolism of polyphenols and impact on health. Biomed. Pharmacother. 2002;56:276–282
  9. Tijburg LBM, Mattern T, Folts JD, Weisgerber UM, Katan MB. Tea flavonoids and cardiovascular diseases: a review. Crit. Rev. Food Sci. Nutr. 1997;37:771–785
  10. Weisburger JH. Tea and health: the underlying mechanisms. Proc. Soc. Exp. Biol. Med. 1999;220:271–275
  11. Wiseman SA, Balentine DA, Frei B. Antioxidants in tea. Crit. Rev. Food Sci. Nutr. 1997;37:705–718
  12. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 2003;43:89–143
  13. Rasmussen SE, Breinholt VM. Non-nutritive bioactive food constituents of plants: bioavailability of flavonoids. Int. J. Vit. Nutr. Res. 2003;73:101–111
  14. Olthof MR, Hollman PCH, Buijsman MNCP, van Amelsvoort JMM, Katan MB. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 2003;133:1806–1814
  15. Catterall F, King LJ, Clifford MN, Ioannides C. Bioavailability of dietary doses of H-3-labelled tea antioxidants (+)-catechin and (−)-epicatechin in rat. Xenobiotica. 2003;33:743–753
  16. Kloots WJ, van Amelsvoort JMM, Brink EJ, Ritskes J, Remie R. Technique for creating a permanent cecal fistula in the rat. Lab. Anim. Sci. 1995;45:588–591
  17. Remie R, van Dongen JJ, Rensema JW, van Wunnik GJH. Permanent cannulation of the portal vein. In:  Huston JP editors. Manual of microsurgery on the laboratory rat. Amsterdam: Elsevier; 1990;p. 213–222
  18. Mulder TPJ, van Platerink CJ, Schuyl PJW, van Amelsvoort JMM. Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatography B. 2001;760:271–279
  19. Baba S, Osakabe N, Natsume M, Terao J. Absorption and urinary excretion of procyanidin B2 [epicatechin-(4 beta-8)-epicatechin] in rats. Free Radic. Biol. Med. 2002;33:142–148
  20. Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB. Absorption of dietary quercetin glucosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995;62:1276–1282
  21. Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C. Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997;409:12–16
  22. van Amelsvoort JMM, van het Hof KH, Mathot JNJJ, Mulder TPJ, Wiersma A, Tijburg LBM. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica. 2001;31:891–901
  23. Zhu M, Chen Y, Li RC. Oral absorption and bioavailability of tea catechins. Plant. Med. 2000;66:444–447
  24. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 1998;7:351–354
  25. Manach C, Texier O, Morand C, Crespy V, Regerat F, Demigne C, et al. Comparison of the bioavailability of quercetin and catechin in rats. Free Radic. Biol. Med. 1999;27:1259–1266
  26. Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J. In vivo comparison of the bioavailability of (+)-catechin, (−)-epicatechin and their mixture in orally administered rats. J. Nutr. 2001;131:2885–2891
  27. Chen LS, Lee MJ, Li H, Yang CS. Absorption, distribution and elimination of tea polyphenols in rats. Drug Metab. Dispos. 1997;25:1045–1050
  28. Piskula MK, Terao J. Accumulation of (−)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissue. J. Nutr. 1998;128:1172–1178
  29. Piskula MK, Terao J. Quercetin's solubility affects its accumulation in rat plasma after oral administration. J. Agric. Food Chem. 1998;46:4313–4317
  30. Manach C, Texier O, Regerat F, Agullo G, Demigne C, Remesy C. Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin. J. Nutr. Biochem. 1996;7:375–380
  31. Abd El Mohsen MM, Kuhnle G, Rechner A, Schroeter H, Rose S, Jenner P, et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Res. 2003;33:1693–1702
  32. Graefe EU, Derendorf H, Veit M. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int. J. Clin. Pharmacol. Ther. 1999;37:219–233
  33. Natsume M. Structures of (−)-epicatechin glucuronide identified from plasma and urine. Free Radic. Biol. Med. 2003;34:840–849
  34. Watanabe H. The chemical structure of the intermediate metabolism of catechin. Bull. Agric. Chem. Soc. Jpn. 1959;23:257–271
  35. Li C, Lee MJ, Sheng S, Meng X, Prabhu S, Winnik B, et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea consumption. Chem. Res. Toxicol. 2000;13:177–184
  36. Schneider H, Blaut M. Anaerobic degradation of flavonoids by Eubacterium ramulus. Arch. Microbiol. 2000;173:71–75
  37. Hollman PCH, Tijburg LBM, Yang CS. Bioavailability of flavonoids from tea. Crit. Rev. Food Sci. Nutr. 1997;37:719–738
  38. Gott DM, Griffiths LA. Effects of antibiotic pretreatments on the metabolism and excretion of [U14C](+)-catechin ([U14C](+)-cyanidanol-3) and its metabolite, 3′-0-methyl-(+)-catechin. Xenobiotica. 1987;17:423–434
  39. Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. 1998;275:R212–R219
  40. Wittig J, Herderich M, Graefe EU, Veit M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 2001;753:237–243
  41. Azuma K, Ippoushi K, Ito H, Higashio H, Terao J. Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J. Agric. Food Chem. 2000;50:1706–1712
  42. Ueno I, Nakano N, Hirono I. Metabolic fate of [14C]quercetin in the ACI rat. Japan J. Exp. Med. 1983;53:41–50
  43. Harada M, Kan Y, Naoki H, Fukui Y, Kageyama N, Nakai M, et al. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (−)-epicatechin. Biosci. Biotechnol. Biochem. 1993;63:973–977
  44. Walle T, Walle UK, Halushka PV. Carbon dioxide is the major metabolite of quercetin in humans. J. Nutr. 2001;131:2648–2652
  45. Meselhy MR, Nakamura N, Hattori M. Biotransformation of (−)-epicatechin 3-O-gallate by human intestinal bacteria. Chem Pharm Bull; 45:888-93.
  46. Blaut M, Schoefer L, Braune A. Transformation of flavonoids by intestinal microorganisms. Int. J. Vitam. Nutr. Res. 2003;73:79–87

PII: S0271-5317(05)00013-8

doi: 10.1016/j.nutres.2004.10.013

Nutrition Research
Volume 25, Issue 3 , Pages 305-317 , March 2005

Article Tools

* Image Usage & Resolution